LC
HZNP

Lindbrook Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Lindbrook Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,671
Closed -$193K – 2869
2023
Q3 		$193K Sell
1,671
-2
-0.1% -$215 0.02% 323
2023
Q2 		$172K Sell
1,673
-27
-2% -$2.85K 0.02% 365
2023
Q1 		$186K Sell
1,700
-5,113
-75% -$565K 0.02% 331
2022
Q4 		$775K Buy
6,813
+70
+1% +$5.81K 0.1% 135
2022
Q3 		$417K Sell
6,743
-58
-0.9% -$4.05K 0.07% 169
2022
Q2 		$542K Buy
6,801
+8
+0.1% +$758 0.09% 138
2022
Q1 		$715K Sell
6,793
-6
-0.1% -$585 0.11% 117
2021
Q4 		$733K Buy
6,799
+5,811
+588% +$634K 0.11% 117
2021
Q3 		$108K Buy
988
+226
+30% +$23.5K 0.03% 254
2021
Q2 		$71K Sell
762
-200
-21% -$18.4K 0.02% 371
2021
Q1 		$89K Sell
962
-554
-37% -$46.8K 0.02% 301
2020
Q4 		$111K Buy
1,516
+536
+55% +$39.8K 0.03% 229
2020
Q3 		$76K Buy
980
+808
+470% +$55.6K 0.02% 260
2020
Q2 		$10K Sell
172
-34
-17% -$1.46K ﹤0.01% 852
2020
Q1 		$6K Sell
206
-794
-79% -$26.9K ﹤0.01% 963
2019
Q4 		$36K Hold
1,000
– – 0.01% 550
2019
Q3 		$27K Hold
1,000
– – 0.01% 622
2019
Q2 		$24K Hold
1,000
– – 0.01% 640
2019
Q1 		$26K Hold
1,000
– – 0.01% 618
2018
Q4 		$19K Buy
+1,000
New +$19.6K 0.01% 641

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's HZNP Position: Q4 2023 in Review

Lindbrook Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,671 shares — an estimated $193K sold.

Lindbrook Capital first reported a position in HZNP in Q4 2018 and held it in 20 quarters. The position peaked at $775K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Lindbrook Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Lindbrook Capital sold 1,671 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $193K.
  • Lindbrook Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • Lindbrook Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $775K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.